Barclays Sets $OSCR (Oscar Health) Underweight: EPS Forecasts Diverge Sharply
Barclays has initiated coverage on Oscar Health with an Underweight rating, projecting a 2027 EPS of $1.28. This starkly contrasts with Oscar’s optimistic target of $2.25+, highlighting a significant divergence...